Amneal to Report Third Quarter 2022 Results on November 4, 2022

Rhea-AI Summary

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) will release its third quarter 2022 financial results on November 4, 2022, before market open. A conference call and live webcast for investors will follow at 8:30 a.m. Eastern Time. Access to the financial results and the live webcast is available on the Investor Relations section of the website. Callers can join by dialing 1 (844) 200-6205 or 1 (929) 526-1599 for international access, using access code 585341.

A replay will be available shortly after the call.

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its third quarter 2022 financial results on Friday November 4, 2022, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on November 4, 2022.

The financial results and live webcast will be accessible through the Investor Relations section of the Company's website at https://investors.amneal.com.

To access the call through a conference line, dial 1 (844) 200-6205 (in the U.S.) or 1 (929) 526-1599 (international callers). The access code for the call is 585341.

A replay of the conference call will be posted shortly after the call and will be available for seven days. To access the replay, dial 1 (866) 813-9403 (in the U.S.) or +44 (204) 525-0658 (international callers). The access code for the replay is 049751.

About Amneal

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is a fully integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals, primarily within the United States. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across a broad range of complex products and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceutical products focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more, please visit www.amneal.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221006005069/en/

Anthony DiMeo

Head of Investor Relations

Anthony.DiMeo@amneal.com

Source: Amneal Pharmaceuticals, Inc.

FAQ

When will Amneal Pharmaceuticals release its third quarter 2022 financial results?

Amneal Pharmaceuticals will release its third quarter 2022 financial results on November 4, 2022, prior to market open.

What time is the Amneal Pharmaceuticals conference call for Q3 2022 results?

The conference call for Amneal Pharmaceuticals' Q3 2022 results will be held at 8:30 a.m. Eastern Time on November 4, 2022.

How can I access the Amneal Pharmaceuticals conference call?

You can access the Amneal Pharmaceuticals conference call by dialing 1 (844) 200-6205 for the U.S. or 1 (929) 526-1599 for international callers, using access code 585341.

Where can I find the live webcast for Amneal Pharmaceuticals' financial results?

The live webcast for Amneal Pharmaceuticals' financial results can be found on the Investor Relations section of their website at investors.amneal.com.

Is there a replay available for the Amneal Pharmaceuticals conference call?

Yes, a replay of the Amneal Pharmaceuticals conference call will be available shortly after the call and for seven days thereafter.